Natural Capsules Limited

Equities

NATCAPSUQ6

INE936B01015

Pharmaceuticals

Delayed Bombay S.E. 01:15:17 2024-05-02 am EDT 5-day change 1st Jan Change
338 INR -1.26% Intraday chart for Natural Capsules Limited -7.04% -6.05%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Natural Capsules Begins Production in First High-Speed HPMC Line MT
Natural Capsules Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Natural Capsules Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Natural Capsules Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Natural Capsules Raises INR750 Million from Somerset Indus Capital Partners MT
Natural Capsules Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Natural Biogenex Private Limited announced that it expects to receive INR 750.000038 million in funding from Natural Capsules Limited, Somerset Indus Capital Partners CI
Natural Capsules Unit Gets INR 6.3 Million Investment MT
Natural Capsules Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Natural Capsules Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Natural Capsules Approves Resignation of Mr. Anjan Kumar as Independent Director CI
Natural Capsules Sees Surge in Fiscal Q4 Consolidated Net Profit MT
Natural Capsules Names New CFO MT
Natural Capsules Limited Announces Chief Financial Officer Changes CI
Natural Capsules Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Natural Capsules Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Natural Capsules Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Natural Capsules Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Natural Capsules Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Natural Capsules Limited Approves Capacity Expansion Plan CI
Natural Capsules Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Natural Capsules Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Natural Capsules Limited cancelled the acquisition of API Business of Naari Pharma Private Limited. CI
Natural Capsules Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Natural Capsules Limited Announces Intimation of Incorporation of Wholly Owned Subsidiary Company CI
Chart Natural Capsules Limited
More charts
Natural Capsules Limited is an India-based hard capsule shell manufacturer, specialized in the manufacturing of vegetarian capsules. The Company's product portfolio includes capsules and steroidal active pharmaceutical ingredients (APIs). Its offerings include hard gelatin capsules, hydroxypropyl methylcellulose (HPMC) vegetarian capsules and others, including shiny capsules, sweet capsules, fast-release capsules, regulatory variants, sodium laureth sulfate (SLS) free capsules, preservative free capsules and transmissible spongiform encephalopathy (TSE) free capsules. The Company, through its subsidiary, Natural Biogenex Private Limited, is focused on manufacturing APIs such as prednisolone, betamethasone, dexamethasone, and hydrocortisone along with their derivatives. The Company exports its products to over 30 countries. It has two manufacturing facilities that are located in Bengaluru and Puducherry. It has a production capacity of around five million capsules per machine per day.
More about the company
  1. Stock Market
  2. Equities
  3. NATCAPSUQ6 Stock
  4. News Natural Capsules Limited
  5. Natural Capsules Begins Production in First High-Speed HPMC Line